Fasenra pen 30 MG/mlml

Ended Awarded

Contract number
SPE2DR26FFAK2
Awardee
Awarding agency
Obligated
$4,389

Award facts

Contract value 100% obligated
$4,389.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $4,389 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 17, 2026, for Fasenra (reslizumab) 30 mg/ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). Place of performance is Park Ridge, IL. The order carries a firm fixed price and an ultimate completion date of July 20, 2026.

PPV-G GEN V is a single-award indefinite delivery contract held by DMS Pharmaceutical with a $499.999 billion ceiling through December 31, 2036, supporting pharmaceutical and medical consumable supply to Department of Defense military healthcare facilities worldwide.

Quick answers

Who was awarded contract SPE2DR26FFAK2?

SPE2DR26FFAK2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 17, 2026.

How much is contract SPE2DR26FFAK2 worth?

The government has obligated $4,389 on SPE2DR26FFAK2.

Is contract SPE2DR26FFAK2 an order under another contract?

Yes. SPE2DR26FFAK2 is a delivery order under SPE2DR25D9223, an indefinite delivery contract.

Was contract SPE2DR26FFAK2 competed?

The extent of competition for SPE2DR26FFAK2 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award